Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Poppelaars

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Complement genetics: from variation to vulnerabilityFelix Poppelaars, Bernardo Faria
Molecular Immunology|November 2, 2020
Complement-mediated kidney diseasesFelix Poppelaars, Joshua M Thurman
Molecular Immunology|December 20, 2016
Complement-mediated inflammation and injury in brain dead organ donorsFelix Poppelaars, Marc A Seelen
Kidney International|October 16, 2025
Granzyme K sets complement in motionFelix Poppelaars, Mohamed R Daha
The New England Journal of Medicine|May 14, 2025
Alternative Complement Pathway, Iptacopan, and IgA NephropathyFelix Poppelaars, Bernardo Faria, Joshua M Thurman
Lancet (London, England)|March 29, 2026
Complement biomarkers during iptacopan treatmentFelix Poppelaars, V Michael Holers, Joshua M Thurman
The Journal of Clinical Investigation|June 16, 2025
Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement researchFelix Poppelaars, V Michael Holers, Joshua M Thurman
Journal of Clinical Medicine|October 23, 2021
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?Felix Poppelaars, Bernardo Faria, Wilhelm Schwaeble, et al.
Molecular Immunology|June 1, 2017
Complement in renal transplantation: The road to translationNeeltina M Jager, Felix Poppelaars, Mohamed R Daha, et al.
Scientific Reports|August 14, 2021
Donor genetic variants in interleukin-6 and interleukin-6 receptor associate with biopsy-proven rejection following kidney transplantationFelix Poppelaars, Mariana Gaya da Costa, Siawosh K Eskandari, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Complement genetics: from variation to vulnerabilityFelix Poppelaars, Bernardo Faria
Molecular Immunology|November 2, 2020
Complement-mediated kidney diseasesFelix Poppelaars, Joshua M Thurman
Molecular Immunology|December 20, 2016
Complement-mediated inflammation and injury in brain dead organ donorsFelix Poppelaars, Marc A Seelen
Kidney International|October 16, 2025
Granzyme K sets complement in motionFelix Poppelaars, Mohamed R Daha
The New England Journal of Medicine|May 14, 2025
Alternative Complement Pathway, Iptacopan, and IgA NephropathyFelix Poppelaars, Bernardo Faria, Joshua M Thurman
Lancet (London, England)|March 29, 2026
Complement biomarkers during iptacopan treatmentFelix Poppelaars, V Michael Holers, Joshua M Thurman
The Journal of Clinical Investigation|June 16, 2025
Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement researchFelix Poppelaars, V Michael Holers, Joshua M Thurman
Journal of Clinical Medicine|October 23, 2021
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?Felix Poppelaars, Bernardo Faria, Wilhelm Schwaeble, et al.
Molecular Immunology|June 1, 2017
Complement in renal transplantation: The road to translationNeeltina M Jager, Felix Poppelaars, Mohamed R Daha, et al.
Scientific Reports|August 14, 2021
Donor genetic variants in interleukin-6 and interleukin-6 receptor associate with biopsy-proven rejection following kidney transplantationFelix Poppelaars, Mariana Gaya da Costa, Siawosh K Eskandari, et al.
Pageof 5